Montega keeps EUR 23 target for Medios stock

Published on 10/18/2026 at 13:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue reached EUR 1.075 billion, up 8.40 percent year over year. Medios stock gets 2026 guidance of EUR 2.10 billion to EUR 2.16 billion.

Analyst target and growth plan

Montega retained its Buy rating and EUR 23.00 target on October 2, 2026.
Medios reported EUR 1.075 billion in first-half 2026 revenue, up 8.40 percent year over year.
Medios stock closed at EUR 10.38 on October 16, 2026.
Caelo is expected to contribute EUR 40.00 million in 2026 revenue after Medios acquired 74.00 percent.

Bauhaus-Poster mit geometrischen Formen und großem Schriftzug PHARMA in Rot, Schwarz und Gelb — Medios AG (DE000A1MMCC8) wird als geometrisches Bauhaus-Poster mit dem Sektor-Schriftzug PHARMA visualisiert, Illustration mit AI erstellt.

Montega retained its Buy rating and EUR 23.00 target for Medios (ISIN DE000A1MMCC8) on October 2, 2026, while the company continues integrating its Caelo acquisition. The first-half 2026 revenue figure was EUR 1.075 billion, up 8.40 percent year over year.

Caelo adds a European platform

According to EQS Group, Medios completed the acquisition of 74.00 percent of Caesar & Loretz GmbH, known as Caelo, on October 1, 2026. The transaction gives Medios a German platform for active pharmaceutical ingredients, excipients and compounding materials.

What does the 74 percent stake add?

Medios expects Caelo to generate EUR 40.00 million in revenue and EUR 1.60 million in earnings before interest, taxes, depreciation and amortization in 2026. The company has about 240 employees, while the transaction consideration was EUR 9.40 million, including EUR 7.90 million for the 74.00 percent stake, according to Yahoo Finance.

Three milestones shape the plan

The recent chronology is clear: on August 12, 2026, Medios reported first-half revenue of EUR 1.075 billion; on September 29, 2026, it presented a EUR 3.1 billion revenue ambition for 2031; and on October 1, 2026, it completed the 74.00 percent Caelo acquisition. The company linked the strategy to a goal of doubling adjusted EBITDA to EUR 170 million by 2031 in its release carried by EQS Group.

Dates for the next update

The next substantiated reporting date is November 10, 2026, when Medios is scheduled to publish its third-quarter statement, according to Yahoo Finance. That release will show whether the higher-growth Compounding strategy is beginning to offset pressure on operating margins.

Stock stays below the target

Montega's EUR 23.00 target is more than twice the last Xetra close, but the analyst note also pointed to regulatory pressure and execution risk. For investors, the key test is whether Caelo's expected EUR 40.00 million revenue contribution can support the margin ambitions set out for 2031.

The last available Xetra closing price was EUR 10.38 on October 16, 2026. The further course of trading is shown by the continuously updated real-time quote of Medios stock.